NeoCremar has been selected as a joint research institution and has completed the agreement for the 'Development and Commercialization of Digestive Health Care Food Ingredients' project, a leading R&D initiative under the 'Regional Innovation Cluster Fosterage (R&D) Program' supported by the Ministry of Trade, Industry and Energy.
This project is led by Hamsoa Pharmaceutical Co., Ltd., with NeoCremar and the Korea Food Research Institute (KFRI) participating as joint research institutions, and will be conducted from 2026 to 2030. The project aims to develop functional ingredients to promote digestive health using AI technology, organoids, and multi-omics technologies, and to establish a foundation for the commercialization of health functional foods and care foods.
Through this project, NeoCremar plans to strengthen its research capabilities in functional ingredients, contribute to the development of next-generation functional ingredients in the digestive health sector, and commercialize individually approved health functional foods. Furthermore, based on industry-academia-research collaboration, we intend to enhance our competitiveness in domestic and global markets and secure new growth opportunities.
We will continue to do our best to strengthen our competitiveness in the functional ingredients sector and enhance corporate value through continuous research and development and technological innovation.